about
Alpha2-adrenergic agonists for the management of opioid withdrawalAlpha2-adrenergic agonists for the management of opioid withdrawalAlpha 2 -adrenergic agonists for the management of opioid withdrawalSelective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in miceClonidine therapy for narcotic withdrawalClonidine for sedation in the critically ill: a systematic review and meta-analysis (protocol)Tobacco addiction and the dysregulation of brain stress systems.Naloxone reverses the antihypertensive effect of clonidineEffect of chronic morphine treatment on alpha(2)-adrenoceptor mediated autoinhibition of transmitter release from sympathetic varicosities of the mouse vas deferensEffects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodentsInvolvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawalGenetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS)Clonidine for sedation and analgesia for neonates receiving mechanical ventilation.Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinenceEffects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area.Opioid dependence treatment: options in pharmacotherapy.Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers.Post-traumatic stress disorder: a review of psychobiology and pharmacotherapy.The use of tramadol for acute heroin withdrawal: a comparison to clonidine.Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.Clonidine in adults as a sedative agent in the intensive care unitDifferential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.Marijuana withdrawal syndrome in the animal model.Neonatal opiate withdrawal.Opioid peptides and primary biliary cirrhosis.Managing sedation withdrawal in children who undergo prolonged PICU admission after discharge to the ward.Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in ratsThe properties of the clonidine withdrawal response of guinea-pig isolated ileumCortical acetylcholine release is increased and gamma-aminobutyric acid outflow is reduced during morphine withdrawalThe inhibitory effects of presynaptic alpha-adrenoceptor agonists on contractions of guinea-pig ileum and mouse vas deferens in the morphine-dependent and withdrawn states produced in vitro.The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteersNeonatal animal models of opiate withdrawal.Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localizationA case of narcotic bowel syndrome successfully treated with clonidine.The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration.Heart failure due to 'stress cardiomyopathy': a severe manifestation of the opioid withdrawal syndrome
P2860
Q24185795-4C49268F-A9FC-4CEC-A970-E64BA82FFDE5Q24197769-D0BC69A5-18E7-40F6-A481-47CD483A65C8Q24241305-97F3E624-4CD5-413B-906A-452FB919CDC5Q24674933-F937F75D-9CDA-4C51-962B-6148AE7907BEQ24675526-E66F280A-0BD9-4032-9228-1EBF59A218FAQ26778976-69AE7446-38D0-4CE9-908D-517985C858CEQ28111988-07A6ACA1-3CEF-480C-96C2-ACFBFA61C326Q28322877-C1D47631-7C25-440A-A889-EC8FC09DDDA6Q28346375-3829CC8C-E508-45BB-ABBF-568D8B931B2EQ28363862-DDFBDB5C-FDAB-498D-BC80-4A2AA0189D21Q28480798-C2F9C700-A824-45B3-8AAC-F3EAD21DFBFBQ28652508-0FD0C728-94FD-454A-B37A-864FB0B861C8Q30234508-A1092A25-5626-4D78-913F-D45E179C92C4Q30455336-550A660F-975E-4E6B-A8D7-E40E0E26AE47Q30476918-D5C11EE7-ABF6-4F01-B419-EEF0257B4375Q33494795-5BDBD81A-10EC-49E6-98FA-499144D3A27BQ33521164-4E39353C-7F63-4469-A9FD-D0C0CCFF077AQ33573243-DC787A5E-EF09-432C-9D06-A644D500018FQ33868638-15BFA088-036C-4D08-B15C-727FED213E27Q34417014-D5AF73AC-6D39-4834-808C-B5C853730649Q34487670-EC7C23E0-F778-40A3-957E-FE18DC46A27DQ34544544-A329B3ED-BB9B-40E2-83A8-5EB4E8FBCAB6Q34613312-9FB8FBF3-9F28-4F90-91F6-25345EC6268DQ34701089-CA56EC41-F567-4581-8B04-6F8ED8C76B8BQ34921130-6AC96DDE-57A6-462A-8C77-941B9A510C13Q34973799-33E5852A-9DC2-4FE0-9892-B8B053B1BC29Q34986723-0787A2AC-FACA-4EEC-851B-3C23170CEE85Q35603523-29A1F10F-E7C0-4397-B1BA-F10844ED77E1Q35706319-9245187C-363E-44DB-BB93-DE1A7F7A58A5Q35743809-8A2B4D6A-CECF-4CD7-A4D9-4C76BA24E88BQ35859810-CF39D899-474F-4013-84F1-7663CD96570EQ35886488-F987557E-ADB1-4BFD-B656-1EBF390B7C3EQ35887564-5010EDF5-9FE9-4B79-B679-88B26C088611Q36095844-718639CD-63E4-4092-9CC8-600FD81D281CQ36279074-1E19C6D3-0E3D-4F0F-AFB4-D5FA3AEA09B7Q36359748-D0329C86-D1F0-4E37-8DAB-85C29D42E74EQ36361567-F19F7B86-E7F2-406B-B0D5-0F3A563EADFAQ36678999-65CEA1D3-1FE7-4BE6-9712-B3CF5CAE0134Q37088654-A289B107-2675-4DFE-93F9-B133D4B3E68AQ37141039-0BBFBDAC-D0E9-479B-A125-6F721376BEC0
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Clonidine blocks acute opiate-withdrawal symptoms.
@en
Clonidine blocks acute opiate-withdrawal symptoms.
@nl
type
label
Clonidine blocks acute opiate-withdrawal symptoms.
@en
Clonidine blocks acute opiate-withdrawal symptoms.
@nl
prefLabel
Clonidine blocks acute opiate-withdrawal symptoms.
@en
Clonidine blocks acute opiate-withdrawal symptoms.
@nl
P2093
P1433
P1476
Clonidine blocks acute opiate-withdrawal symptoms.
@en
P2093
P304
P356
10.1016/S0140-6736(78)92823-4
P407
P577
1978-09-01T00:00:00Z